TY - JOUR Y1 - 2023/10// KW - long-COVID-19 KW - comorbidity KW - diabetes KW - cardiovascular disease KW - Banglades AV - public VL - 11 JF - Frontiers in Public Health A1 - Sharif, Nadim A1 - Sharif, Nazmul A1 - Khan, Afsana A1 - Halawani, Ibrahim F. A1 - Alzahrani, Fuad M. A1 - Alzahrani, Khalid J. A1 - Díez, Isabel De la Torre A1 - Ramírez-Vargas, Debora L. A1 - Kuc Castilla, Ángel Gabriel A1 - Parvez, Anowar Khasru A1 - Dey, Shuvra Kanti N2 - Introduction: Co-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh. Methods: We collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival. Results: COVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79?4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients. Discussion: Risk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh. TI - Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh UR - http://doi.org/10.3389/fpubh.2023.1222868 ID - uninimx9478 SN - 2296-2565 ER -